This company listing is no longer active
N1K Stock Overview
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NewAge, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.081 |
| 52 Week High | US$1.24 |
| 52 Week Low | US$0.081 |
| Beta | 1.55 |
| 1 Month Change | -67.72% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -97.37% |
| Change since IPO | -97.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| N1K | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | -55.9% | 1.5% | -0.3% |
| 1Y | n/a | 0.7% | 2.8% |
Return vs Industry: Insufficient data to determine how N1K performed against the German Personal Products industry.
Return vs Market: Insufficient data to determine how N1K performed against the German Market.
Price Volatility
| N1K volatility | |
|---|---|
| N1K Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: N1K's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine N1K's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 1,109 | Ed Brennan | www.newage.com |
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products.
NewAge, Inc. Fundamentals Summary
| N1K fundamental statistics | |
|---|---|
| Market cap | €13.77m |
| Earnings (TTM) | -€7.16m |
| Revenue (TTM) | €440.94m |
0.0x
P/S Ratio-1.9x
P/E RatioIs N1K overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| N1K income statement (TTM) | |
|---|---|
| Revenue | US$439.53m |
| Cost of Revenue | US$142.56m |
| Gross Profit | US$296.98m |
| Other Expenses | US$304.11m |
| Earnings | -US$7.14m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.049 |
| Gross Margin | 67.57% |
| Net Profit Margin | -1.62% |
| Debt/Equity Ratio | 7.9% |
How did N1K perform over the long term?
See historical performance and comparison